Kewaunee Scientific Q3 Financial Highlights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Should l Buy KEQU?
Source: seekingalpha
- Earnings Performance: Kewaunee Scientific reported a Q3 GAAP EPS of $0.23, indicating stability in profitability despite facing market challenges.
- Revenue Growth: The company achieved revenues of $69.4 million in Q3, reflecting a year-over-year increase of 3.3%, showcasing sustained demand in the laboratory equipment market and an expanding customer base.
- Market Performance Analysis: Although the revenue growth rate is modest, the stable profitability and slight increase suggest that the company maintains a solid competitive position in the industry, potentially attracting more investor interest.
- Future Outlook: Kewaunee Scientific's financial performance lays a foundation for future growth, and management may leverage this positive trend to drive new product development and market expansion strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KEQU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KEQU
About KEQU
Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kewaunee Scientific Q3 Financial Highlights
- Earnings Performance: Kewaunee Scientific reported a Q3 GAAP EPS of $0.23, indicating stability in profitability despite facing market challenges.
- Revenue Growth: The company achieved revenues of $69.4 million in Q3, reflecting a year-over-year increase of 3.3%, showcasing sustained demand in the laboratory equipment market and an expanding customer base.
- Market Performance Analysis: Although the revenue growth rate is modest, the stable profitability and slight increase suggest that the company maintains a solid competitive position in the industry, potentially attracting more investor interest.
- Future Outlook: Kewaunee Scientific's financial performance lays a foundation for future growth, and management may leverage this positive trend to drive new product development and market expansion strategies.
See More
Kewaunee to Showcase at 2026 analytica Tradeshow in Munich
- Exhibition Opportunity: Kewaunee Scientific Corporation will attend the analytica tradeshow in Munich from March 24-27, 2026, showcasing its laboratory infrastructure and safety solutions alongside its recently acquired subsidiary, Nu Aire, and is expected to attract over 30,000 professionals, enhancing brand visibility and market influence.
- Product Portfolio Showcase: The event will feature a comprehensive product lineup from Kewaunee and Nu Aire, including biological safety cabinets and CO2 incubators, aimed at addressing modern laboratory needs for safety and efficiency, thereby enhancing customer trust and driving sales growth.
- Industry Partnerships: Kewaunee will collaborate with its European market partner, ibs tecnomara, to demonstrate how coordinated infrastructure and containment solutions can enhance laboratory performance, further solidifying its leadership position in the industry.
- Strategic Commitment: Kewaunee's CEO, Thomas D. Hull III, emphasized that the tradeshow represents a vital opportunity to connect with global laboratory users and partners, showcasing the company's commitment to supporting laboratory projects throughout their lifecycle, indicating potential for future business growth.
See More
Kewaunee Scientific to Release Q3 FY2026 Financial Results
- Earnings Release Schedule: Kewaunee Scientific Corporation plans to announce its third quarter fiscal year 2026 financial results on March 11, 2026, after market close, which is expected to provide investors with insights into the company's financial health and operational performance.
- Company Overview: Founded in 1906, Kewaunee is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework and fume hoods, serving both domestic and international markets.
- Acquisition Details: The recent acquisition of Nu Aire, a manufacturer of biological safety cabinets and ultra-low freezers, enhances Kewaunee's product portfolio, thereby strengthening its competitive position in the laboratory equipment market.
- Global Business Presence: Kewaunee operates sales offices in the U.S., India, Saudi Arabia, and Singapore, with manufacturing facilities in Statesville and Bangalore, reflecting its strategic focus on global market expansion and production capabilities.
See More
Agnico Eagle Mines Stock Rises 63.4% Over Six Months
- Stock Performance: Agnico Eagle's shares have surged 63.4% over the past six months, outperforming the Zacks Mining - Gold industry, which gained 85.9%, indicating its relative strength in the market.
- Earnings Estimates Rising: The company's earnings estimates for Q4 2025 have been increasing over the past month, reflecting growing market confidence in its future growth potential, particularly with cost savings expected from the Kittila expansion project.
- Strengthened Market Position: The merger with Kirkland Lake Gold has established Agnico Eagle as the industry's highest-quality senior gold producer, with a robust pipeline of development and exploration projects ensuring sustainable growth.
- Diversification Strategy: By maintaining prudent debt management and financial flexibility, the company mitigates risks, with higher gold prices expected to further enhance its margins, thereby boosting investor confidence.
See More
Agnico Eagle Mines (AEM) Q4 Earnings Outlook Improves, Shares Up 63.4% Over Six Months
- Earnings Outlook Improvement: Agnico Eagle Mines has seen its stock rise 63.4% over the past six months, outperforming the Zacks Mining - Gold industry’s 85.9% gain, reflecting market optimism regarding its Q4 earnings estimates.
- Project Expansion and Acquisitions: The company is enhancing its market position through the Kittila expansion project and acquisitions like Hope Bay, along with the merger with Kirkland Lake Gold, which are expected to drive future production growth and cost savings.
- Enhanced Financial Flexibility: Agnico Eagle mitigates risks through prudent debt management and strategic diversification, while higher gold prices are anticipated to boost the company's margins, further strengthening its financial stability.
- Sustainable Growth Pipeline: The merged entity now possesses an extensive pipeline of development and exploration projects, ensuring potential for sustainable growth that aligns with industry demand for high-quality gold producers.
See More
Kewaunee Reports 46.8% Sales Growth in Q2 FY2026
- Significant Sales Growth: Kewaunee reported sales of $70.1 million for Q2 FY2026, reflecting a 46.8% increase from $47.8 million in the same quarter last year, indicating strong market demand and operational performance.
- Strong Domestic Performance: Domestic sales reached $55.2 million, up 51.7% year-over-year, demonstrating resilience despite lower manufacturing volumes in laboratory construction, with Nu Aire's strong performance offsetting some of the challenges, highlighting the success of the company's diversification strategy.
- Continued International Growth: International sales amounted to $14.9 million, a 31.0% increase from $11.4 million in the prior year, primarily driven by the delivery of large projects booked in previous periods, showcasing the company's expansion potential in global markets.
- Improved Financial Position: As of October 31, 2025, the company had cash on hand of $13.7 million, down from $17.2 million on April 30, but working capital increased to $67.8 million, indicating financial stability amid ongoing investments and growth initiatives.
See More
Kewaunee Scientific Q3 Financial Highlights
- Earnings Performance: Kewaunee Scientific reported a Q3 GAAP EPS of $0.23, indicating stability in profitability despite facing market challenges.
- Revenue Growth: The company achieved revenues of $69.4 million in Q3, reflecting a year-over-year increase of 3.3%, showcasing sustained demand in the laboratory equipment market and an expanding customer base.
- Market Performance Analysis: Although the revenue growth rate is modest, the stable profitability and slight increase suggest that the company maintains a solid competitive position in the industry, potentially attracting more investor interest.
- Future Outlook: Kewaunee Scientific's financial performance lays a foundation for future growth, and management may leverage this positive trend to drive new product development and market expansion strategies.
See More
Kewaunee to Showcase at 2026 analytica Tradeshow in Munich
- Exhibition Opportunity: Kewaunee Scientific Corporation will attend the analytica tradeshow in Munich from March 24-27, 2026, showcasing its laboratory infrastructure and safety solutions alongside its recently acquired subsidiary, Nu Aire, and is expected to attract over 30,000 professionals, enhancing brand visibility and market influence.
- Product Portfolio Showcase: The event will feature a comprehensive product lineup from Kewaunee and Nu Aire, including biological safety cabinets and CO2 incubators, aimed at addressing modern laboratory needs for safety and efficiency, thereby enhancing customer trust and driving sales growth.
- Industry Partnerships: Kewaunee will collaborate with its European market partner, ibs tecnomara, to demonstrate how coordinated infrastructure and containment solutions can enhance laboratory performance, further solidifying its leadership position in the industry.
- Strategic Commitment: Kewaunee's CEO, Thomas D. Hull III, emphasized that the tradeshow represents a vital opportunity to connect with global laboratory users and partners, showcasing the company's commitment to supporting laboratory projects throughout their lifecycle, indicating potential for future business growth.
See More
Kewaunee Scientific to Release Q3 FY2026 Financial Results
- Earnings Release Schedule: Kewaunee Scientific Corporation plans to announce its third quarter fiscal year 2026 financial results on March 11, 2026, after market close, which is expected to provide investors with insights into the company's financial health and operational performance.
- Company Overview: Founded in 1906, Kewaunee is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework and fume hoods, serving both domestic and international markets.
- Acquisition Details: The recent acquisition of Nu Aire, a manufacturer of biological safety cabinets and ultra-low freezers, enhances Kewaunee's product portfolio, thereby strengthening its competitive position in the laboratory equipment market.
- Global Business Presence: Kewaunee operates sales offices in the U.S., India, Saudi Arabia, and Singapore, with manufacturing facilities in Statesville and Bangalore, reflecting its strategic focus on global market expansion and production capabilities.
See More
Agnico Eagle Mines Stock Rises 63.4% Over Six Months
- Stock Performance: Agnico Eagle's shares have surged 63.4% over the past six months, outperforming the Zacks Mining - Gold industry, which gained 85.9%, indicating its relative strength in the market.
- Earnings Estimates Rising: The company's earnings estimates for Q4 2025 have been increasing over the past month, reflecting growing market confidence in its future growth potential, particularly with cost savings expected from the Kittila expansion project.
- Strengthened Market Position: The merger with Kirkland Lake Gold has established Agnico Eagle as the industry's highest-quality senior gold producer, with a robust pipeline of development and exploration projects ensuring sustainable growth.
- Diversification Strategy: By maintaining prudent debt management and financial flexibility, the company mitigates risks, with higher gold prices expected to further enhance its margins, thereby boosting investor confidence.
See More
Agnico Eagle Mines (AEM) Q4 Earnings Outlook Improves, Shares Up 63.4% Over Six Months
- Earnings Outlook Improvement: Agnico Eagle Mines has seen its stock rise 63.4% over the past six months, outperforming the Zacks Mining - Gold industry’s 85.9% gain, reflecting market optimism regarding its Q4 earnings estimates.
- Project Expansion and Acquisitions: The company is enhancing its market position through the Kittila expansion project and acquisitions like Hope Bay, along with the merger with Kirkland Lake Gold, which are expected to drive future production growth and cost savings.
- Enhanced Financial Flexibility: Agnico Eagle mitigates risks through prudent debt management and strategic diversification, while higher gold prices are anticipated to boost the company's margins, further strengthening its financial stability.
- Sustainable Growth Pipeline: The merged entity now possesses an extensive pipeline of development and exploration projects, ensuring potential for sustainable growth that aligns with industry demand for high-quality gold producers.
See More
Kewaunee Reports 46.8% Sales Growth in Q2 FY2026
- Significant Sales Growth: Kewaunee reported sales of $70.1 million for Q2 FY2026, reflecting a 46.8% increase from $47.8 million in the same quarter last year, indicating strong market demand and operational performance.
- Strong Domestic Performance: Domestic sales reached $55.2 million, up 51.7% year-over-year, demonstrating resilience despite lower manufacturing volumes in laboratory construction, with Nu Aire's strong performance offsetting some of the challenges, highlighting the success of the company's diversification strategy.
- Continued International Growth: International sales amounted to $14.9 million, a 31.0% increase from $11.4 million in the prior year, primarily driven by the delivery of large projects booked in previous periods, showcasing the company's expansion potential in global markets.
- Improved Financial Position: As of October 31, 2025, the company had cash on hand of $13.7 million, down from $17.2 million on April 30, but working capital increased to $67.8 million, indicating financial stability amid ongoing investments and growth initiatives.
See More
